UNITEDHEALTH GROUP INC — Form 8-K
Filed July 16, 2026 · analyzed by the 8-K Agent
8-K
▲ Likely positive
significance 42/100
What the filing says
UnitedHealth reported Q2 2026 revenues of $112.0B and operating earnings of $8.0B ($6.04 diluted EPS; $6.38 adjusted). The company raised full-year 2026 guidance to $18.45–$18.95 diluted EPS and $19.50–$20.00 adjusted EPS (from prior $17.10 and $17.75). Key drivers: medical cost ratio improved to 86.7% (vs. 89.4% YoY) through pricing discipline and cost management; operating cash flow $11.1B; $4.0B stock repurchased YTD with ≥$5.0B planned for full year. UnitedHealthcare served 48.5M members (down 525K sequentially); Optum generated $4.0B earnings on $65.7B revenue with 160 bps margin expansion YoY. Company committed $1.0B to United Health Foundation and announced major prior-authorization reforms (30% reduction target by year-end 2026).
Why this rating
Strong quarter with raised guidance is positive, but incremental vs. company scale ($281.9B market cap). Member declines in UnitedHealthcare offset earnings gains. Routine rebalancing, not transformational.
See more from July 16, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.